This research aims to discuss how multinational pharmaceutical companies have responded to the challenges imposed by the COVID-19 pandemic, which would ideally be translated into supplying vaccines in a timely and efficient manner to fight against that emergency. The theoretical approach relies upon the concept of Corporate Social Responsibility (CSR), implying enterprises are supposed to achieve a balance of economic, social, and environmental deliverables while, at the same time, addressing the expectations of both shareholders and stakeholders. The method consists of scrutinizing secondary data—mainly figures of the vaccines provided by the different companies— and qualitative content analysis of the actions they state they have taken, which have been conveyed in press releases and annual reports. The findings show that major corporations have primarily considered the financial aspects of CSR, leaving out the social component they claim to address in their mission statements. Our critical position is that millions of lives could have been saved and relevant economic downturn avoided, particularly in low- and middle-income countries, had there been true practice and implementation of the CSR principles on the pharmaceutical company part.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.